Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cellsMcDonald, Denise M; Alp, Nicholas J; Channon, Keith MPharmacogenetics: December 2004 - Volume 14 - Issue 12 - pp 831-839 Original Articles Abstract Author Information The G894T endothelial nitric oxide synthase (eNOS) polymorphism results in a Glu to Asp substitution at position 298. This position is located externally on the protein and as the regulation of eNOS is dependent on its subcellular localization and interaction with modulatory proteins, we aimed to address whether the substitution of Asp at 298 had any effect on these mechanisms. Initially, we developed a novel method to accurately determine molar quantities of each variant by expressing them as green fluorescent protein (GFP) fusion proteins and using recombinant adenoviruses to facilitate transient infection of human microvascular endothelial cells. Sodium dodecyl sulphate–polyacrylamide gel electrophoresis and Western blotting of eNOS298Asp revealed a 135-kDa proteolytic fragment which was not present with eNOS298Glu. This proteolysis was prevented by using LDS buffer confirming that this differential cleavage is an artefact of sample preparation and unlikely to occur intracellularly. Nitric oxide was measured following stimulation with calcium ionophore or oestrogen in the presence of varying sepiapterin concentrations. GFP fluorescence was used to quantify the amount of fusion protein and calculate intracellular specific activity. There was no significant difference in intracellular specific activity between Glu298 and Asp298 eNOS in response to calcium ionophore or oestrogen. Tetrahydrobiopterin supplementation increased eNOS activity of both variants in an identical manner. The presence of the GFP also facilitated the visualization of the variants by confocal microscopy and demonstrated that both localized to the plasma membrane and the Golgi. These findings demonstrate that the Asp substitution at 298 does not have a major effect in modulating eNOS activity in vivo. Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK. Correspondence and requests for reprints to Denise M. McDonald, Department of Ophthalmology, Queen's University of Belfast, Institute of Clinical Science, Royal Victoria Hospital, Belfast BT12 6BA, UK. E-mail: email@example.com Received 21 May 2004 Accepted 20 September 2004 © 2004 Lippincott Williams & Wilkins, Inc.